Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in QIV vaccinated mice is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
European Commission
Grant: 817938
Synergistic engineering of anti-tumor immunity by synthetic biomaterials
National Institutes of Health
Grant: 5R21AI151229-02
A Miniature Pig Model for the Study of Host-Immune Responses Against Influenza A Virus
National Institutes of Health
Grant: 5R44AI176894-02
7HP349, an oral integrin activator to augment effectiveness of pre-exposure influenza vaccination
National Institutes of Health
Grant: 5R21AI176069-02
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
National Institutes of Health
Grant: 5P01AI097092-04
Monoclonal Antibody Technology Core
NIAID NIH HHS
Grant: R21 AI176069
NIAID NIH HHS
Grant: R21 AI151229
NIAID NIH HHS
Grant: P01 AI097092
NIAID NIH HHS
Grant: 75N93021C00014
NIAID NIH HHS
Grant: 75N93019C00051
NIAID NIH HHS
Grant: R44 AI176894
NIAID NIH HHS
Grant: R01 AI160706
Fields of Study
Keywords
Sustainable Development Goals